|
Identification of optimum spectacle prescriptions for patients with Down syndrome |
5R01EY024590-08 |
|
NEI |
2022 |
|
Applications of high resolution fMRI in ultra-high field (7T) in revealing developmental disorders underlying amblyopia |
5R01EY030434-03 |
|
NEI |
2022 |
|
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome |
5R01AI141662-04 |
|
NIAID |
2022 |
|
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome |
5R01AI143710-04 |
|
NIAID |
2022 |
|
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome |
5R01AI145988-04 |
|
NIAID |
2022 |
|
Mediator kinases as interferon antagonists in Down Syndrome |
5R01AI156739-03 |
|
NIAID |
2022 |
|
The Impact of Maternal CMV Infection on Birth Outcomes |
5R03AI151426-02 |
|
NIAID |
2022 |
|
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome |
5R21AI161827-02 |
|
NIAID |
2022 |
|
Identification of optimum spectacle prescriptions for patients with Down syndrome |
2 R01 EY024590-07A1 |
ANDERSON, HEATHER ANNE |
NEI |
2021 |
|
Short Term Training in Health Professional Schools |
2 T35 EY007088-36 |
FRISHMAN, LAURA J |
NEI |
2021 |